Subprime Lender Goeasy Sees Elevated Writeoffs Before Business Improves

Goeasy reported an adjusted Q4 loss of C$8.93 per share versus the C$4.28 loss expected by analysts, reflecting a substantial earnings miss. The lender said loan writeoffs—driven by a recent surge in vehicle-financing bad debts—will remain elevated for a period before improving later in the year. This weak result and cautious outlook are likely to pressure the stock and continue scrutiny of credit performance in its subprime book.

Analysis

The core actionable takeaway is that specialty subprime origination is now a funding-and-collateral problem more than a pure underwriting miss — that combination amplifies losses through two channels: securitization repricing and accelerating collateral impairment (used-vehicle residuals). A 200–300bp widening in ABS spreads would translate into a ~1.5–2.5% hit to return on assets for a balance-sheet that is 40–60% reliant on wholesale funding, compressing equity value materially within 3–9 months as new originations reprice less profitably.

Competitive dynamics favor originators with scale, access to lower-cost funding, or superior loss-forecasting models. Large Canadian banks (higher deposit shares) and private fintechs with alternative data can selectively expand share as smaller specialty lenders retrench; dealers and remarketers face a squeeze if collateral prices fall another 5–10%, which would add a second wave of losses into repossessions over the next 6–12 months.

Key catalysts to watch are (1) ABS spread moves — a persistent >250bp move wider signals a funding cliff in weeks; (2) a 60–90 day acceleration in repossession recovery costs or reserve increases at peers — that forces mark-to-market repricing; and (3) any opportunistic capital raise which would be a near-term de-risk event. Tail risk is a rapid macro downturn (jobless claims shock) producing cascaded covenant breaches and fire sales inside a 30–120 day window.

Valuation and tradeability: implied downside is asymmetric and front-loaded; volatility will be elevated around quarterly filings and any ABS issuance attempts. Position sizing should assume binary outcomes (capital raise vs bankruptcy restructuring) and plan for 30–60% intraday swings; liquidity in options/CDS will be limited, so execution and slippage matter as much as direction.

Key Decisions for Investors

• Short GSY.TO equity (size 1–3% gross portfolio) on any 10–15% relief rally; target 40–60% downside over 6–12 months if ABS spreads remain impaired. Stop-loss: 25% above entry to limit gamma risk. Expected payoff: 3:1 reward:risk if funding dislocation persists.
• Buy 3–6 month GSY.TO puts ~25–30% out-of-the-money (size 0.5–1% portfolio) to hedge tail credit risk in the book; if premiums are rich, prefer longer-dated (9–12 month) puts to capture restructuring optionality. Risk: premium decay; Reward: protects against >30% equity gap/dilution events.
• Pairs trade: short GSY.TO / long RY.TO or CM.TO (dollar-neutral, size 1–2%) to capture relative outperformance as deposits reprice and risk-weighted capital advantages manifest. Timeframe 3–6 months; expected relative return 300–600bps if specialty funding stays tight.
• Monitor GSY bond/CDS levels for opportunistic long-credit trades only if spreads widen >300bps and management signals a credible capital raise — then selectively buy senior bonds at >10% YTM (risk of restructuring remains). Maintain tight sizing (0.5–1%) given recovery uncertainty.